Mauri, Gianluca
Gori, Viviana
Patelli, Giorgio
Roazzi, Laura
Rizzetto, Francesco
De Carlis, Luciano
Mariani, Anna
Cavallari, Ugo
Prada, Elisabetta
Cipani, Tiziana
Aquilano, Maria Costanza
Bonoldi, Emanuela
Vanzulli, Angelo
Siena, Salvatore
Sartore-Bianchi, Andrea
Funding for this research was provided by:
Università degli Studi di Milano
Article History
Received: 25 November 2022
Accepted: 27 February 2023
First Online: 31 March 2023
Declarations
:
: The patient consented to provide treatments as per institutional and national guidelines. In addition, the patient consented to submission and publication of this case report.
: ASB is an advisory board member for Amgen, Bayer, Novartis, Sanofi, and Servier. AA is an advisory board member for Roche and Bayer and received honoraria from CheckmAb. SS is an advisory board member for Agenus, AstraZeneca, Bayer, BMS, CheckmAb, Daiichi-Sankyo, Guardant Health, Menarini, Merck, Novartis, Roche-Genentech, and Seagen. GM received honoraria from COR2ED. The remaining authors declare no competing interests.